Abnormal uterine and vaginal bleeding. Other abnormal uterine and vaginal bleeding
Conditions
Interventions
Intervention 1: the first group received tranexamic acid 10 mg / kg in 500 ml Ringer serom in 10 minutes. Intervention 2: The second group,five units of oxytocin in 500 ml serum ringer 10 minute intr
Treatment - Drugs
the first group received tranexamic acid 10 mg / kg in 500 ml Ringer serom in 10 minutes
The second group,five units of oxytocin in 500 ml serum ringer 10 minute intravenous infusion
Sponsors
Vice chancellor for Research,Tabriz University Of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: Medium and persistent abnormal uterine bleeding; Report on transvaginal ultrasound submucosal myoma diameter 30 mm or less and grade zero or one; Exclusion criteria: Patients with a history of heart disease; Hepatic; Diabetes; Thromboembolism; Cancer of the uterus and cervix; Submucosal leiomyoma larger than 3 cm; Uterine septum; pregnant women; Severe bleeding; Anti coagulation therapy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The hemoglobin concentration. Timepoint: Six hours after surgery. Method of measurement: Blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of surgery. Timepoint: After surgery. Method of measurement: Questionnaire.;The success of myomectomy. Timepoint: After surgery. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehri Jaefari Shobeiri
Tabriz University Of Medical Sciences
Outcome results
None listed